Randomized Controlled Trial of the Efficacy of Carrageenan as a Topical Microbicide Against HPV Infection.
卡拉胶作为局部杀菌剂对抗 HPV 感染功效的随机对照试验。
基本信息
- 批准号:199135
- 负责人:
- 金额:$ 48.67万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2010
- 资助国家:加拿大
- 起止时间:2010-03-01 至 2015-03-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Worldwide, cervical cancer is the second leading cause of cancer in women. Cervical cancer is most common in Latin and in sub-Saharan Africa, and the Caribbean. Because it is much more common in developing countries, it has been described as a disease of
在世界范围内,宫颈癌是女性癌症的第二大原因。宫颈癌在拉丁美洲、撒哈拉以南非洲和加勒比地区最为常见。因为它在发展中国家更为常见,它被描述为一种疾病,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Franco Eduardo L其他文献
Franco Eduardo L的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Franco Eduardo L', 18)}}的其他基金
The McGill Task Force on the Impact of COVID-19 on Cancer Control and Care: Generating Evidence and Developing Strategies to Mitigate Future Cancer Risk for Canadians
麦吉尔特别工作组研究 COVID-19 对癌症控制和护理的影响:生成证据并制定策略以减轻加拿大人未来的癌症风险
- 批准号:
460247 - 财政年份:2021
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
Impact of the COVID-19 pandemic on cancer care and outcomes in children and adolescents
COVID-19 大流行对儿童和青少年癌症护理和结果的影响
- 批准号:
450625 - 财政年份:2021
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
Mitigating the long-term impact of the COVID-19 epidemic on cancer control and care
减轻 COVID-19 流行病对癌症控制和护理的长期影响
- 批准号:
430201 - 财政年份:2020
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
Validation of epigenetic markers in cervical carcinogenesis
宫颈癌发生中表观遗传标记的验证
- 批准号:
407426 - 财政年份:2019
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
Estimating the harms and benefits of cervical cancer screening in the pre- and post-HPV vaccination eras: a modelling study
估计 HPV 疫苗接种前后时代宫颈癌筛查的危害和益处:一项模型研究
- 批准号:
359040 - 财政年份:2016
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
Research Program on the Epidemiology and Prevention of Human Papillomavirus Infection and Associated Cancers
人乳头瘤病毒感染及相关癌症的流行病学和预防研究计划
- 批准号:
312539 - 财政年份:2014
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
Transmission Reduction and Prevention with HPV Vaccination (TRAP-HPV) Study: A Randomized Controlled Trial of the Efficacy of HPV Vaccination in Preventing Transmission of HPV Infection in Heterosexual Couples
通过 HPV 疫苗接种减少和预防传播 (TRAP-HPV) 研究:针对异性伴侣中 HPV 疫苗接种预防 HPV 感染传播功效的随机对照试验
- 批准号:
266349 - 财政年份:2012
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
HPV Infection and Transmission Among Couples Through Heterosexual Activity (The HITCH Cohort Study)
通过异性性行为在夫妻中感染和传播 HPV(HITCH 队列研究)
- 批准号:
179978 - 财政年份:2009
- 资助金额:
$ 48.67万 - 项目类别:
Operating Grants
相似海外基金
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
- 批准号:
10103126 - 财政年份:2024
- 资助金额:
$ 48.67万 - 项目类别:
EU-Funded
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
- 批准号:
10110442 - 财政年份:2024
- 资助金额:
$ 48.67万 - 项目类别:
EU-Funded
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 48.67万 - 项目类别:
Research Grant
Archer: Next-generation unstructured data access for hospitals and clinical trial sponsors, delivering efficiency, reducing costs and improving care
Archer:为医院和临床试验申办者提供下一代非结构化数据访问,提高效率、降低成本并改善护理
- 批准号:
10096804 - 财政年份:2024
- 资助金额:
$ 48.67万 - 项目类别:
Collaborative R&D
Applying co-production to enhance Ontario's clinical trial landscape
应用联合生产来增强安大略省的临床试验前景
- 批准号:
484616 - 财政年份:2023
- 资助金额:
$ 48.67万 - 项目类别:
Fellowship Programs
The Alzheimer's Disease Tau Platform Clinical Trial
阿尔茨海默病 Tau 平台临床试验
- 批准号:
10655872 - 财政年份:2023
- 资助金额:
$ 48.67万 - 项目类别:
Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments
走向临床试验:AXL-STAT3 靶向肺肿瘤微环境
- 批准号:
10660429 - 财政年份:2023
- 资助金额:
$ 48.67万 - 项目类别:
A randomized clinical trial of client-centered care coordination to improve pre-exposure prophylaxis use for Black men who have sex with men
一项以客户为中心的护理协调的随机临床试验,以改善男男性行为黑人的暴露前预防使用
- 批准号:
10762186 - 财政年份:2023
- 资助金额:
$ 48.67万 - 项目类别:
Early-Stage Clinical Trial of AI-Driven CBCT-Guided Adaptive Radiotherapy for Lung Cancer
AI驱动的CBCT引导的肺癌适应性放疗的早期临床试验
- 批准号:
10575081 - 财政年份:2023
- 资助金额:
$ 48.67万 - 项目类别:
A Randomized Clinical Trial of Continuous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury Biomarkers
连续与间歇输注万古霉素的随机临床试验:对测量的 GFR 和肾损伤生物标志物的影响
- 批准号:
10647236 - 财政年份:2023
- 资助金额:
$ 48.67万 - 项目类别: